INTEGRAL AD SCIENCE HOLDING (IAS) Forecast, Price Target & Analyst Ratings
NASDAQ:IAS • US45828L1089
10.34 USD
+0.08 (+0.78%)
At close: Dec 22, 2025
10.33 USD
-0.01 (-0.1%)
After Hours: 12/22/2025, 8:00:02 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INTEGRAL AD SCIENCE HOLDING (IAS).
Forecast Snapshot
Consensus Price Target
$11.71
+ 13.26% Upside
Next Earnings Forecast
Release DateFeb 26, 2026
PeriodQ4 / 2025
EPS Estimate$0.13
Revenue Estimate171.64M
ChartMill Buy Consensus
54.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$11.71
Upside
+ 13.26%
From current price of $10.34 to mean target of $11.71, Based on 20 analyst forecasts
Low
$10.10
Median
$10.51
High
$18.90
Price Target Revisions
1 Month
0.00%
3 Months
-1.72%
Price Target Summary
20 analysts have analysed IAS and the average price target is 11.71 USD. This implies a price increase of 13.26% is expected in the next year compared to the current price of 10.34.
The average price target has been revised downward by 1.72% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
54.00%
IAS was analyzed by 20 analysts. The buy percentage consensus is at 54. So analysts seem to be rather neutral about IAS.
In the previous month the buy percentage consensus was at a similar level.
IAS was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-09-26 | Stifel | Downgrade | Buy -> Hold |
| 2025-09-25 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2025-09-25 | Baird | Maintains | Neutral -> Neutral |
| 2025-08-08 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-08 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-07-22 | Stifel | Maintains | Buy -> Buy |
| 2025-05-13 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-13 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-05-05 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-04-23 | Stifel | Maintains | Buy -> Buy |
| 2025-04-21 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-17 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-03-28 | Baird | Downgrade | Outperform -> Neutral |
| 2025-03-03 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-03-03 | Truist Securities | Maintains | Buy -> Buy |
| 2025-03-03 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-12-05 | ScotiaBank | Initiate | Sector Perform |
| 2024-11-14 | Benchmark | Reiterate | Hold |
| 2024-11-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-11-13 | Truist Securities | Maintains | Buy -> Buy |
| 2024-11-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-11-13 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-08-05 | Benchmark | Reiterate | Hold |
| 2024-08-05 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-08-02 | Raymond James | Maintains | Outperform -> Outperform |
Next Earnings Forecast Details
Next Earnings Details
Release DateFeb 26, 2026
PeriodQ4 / 2025
EPS Estimate$0.13
Revenue Estimate171.64M
Revenue Q2Q12.16%
EPS Q2Q43.40%
Number of Analysts15
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.23%
EPS (1 Month)
0.00%
EPS (3 Months)
-0.43%
Next Earnings Summary
IAS is expected to report earnings on 2/26/2026. The consensus EPS estimate for the next earnings is 0.13 USD and the consensus revenue estimate is 171.64M USD.
The next earnings revenue estimate has been revised upward by 0.23% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 408.3M 26.21% | 474.369M 16.18% | 530.101M 11.75% | 609.53M 14.98% | 679.18M 11.43% | 760.67M 12.00% | 856.85M 12.64% | 936.77M 9.33% | 1.045B 11.55% | 1.135B 8.61% | 1.226B 8.02% | |
| EBITDA YoY % growth | 70.2M 95.60% | 72.488M 3.26% | 128.279M 76.97% | 213.99M 66.82% | 240.98M 12.61% | 274.67M 13.98% | 308.73M 12.40% | 344.04M 11.44% | 368.75M 7.18% | 405.11M 9.86% | 442.18M 9.15% | |
| EBIT YoY % growth | 19.8M 175.00% | 17.522M -11.51% | 64.313M 267.04% | 74.602M 16.00% | 98.364M 31.85% | 123.39M 25.44% | 123.52M 0.11% | 150.39M 21.75% | 178.47M 18.67% | 207.45M 16.24% | 237.15M 14.32% | |
| Operating Margin | 4.85% | 3.69% | 12.13% | 12.24% | 14.48% | 16.22% | 14.42% | 16.05% | 17.08% | 18.28% | 19.34% | |
| EPS YoY % growth | 0.09 126.43% | 0.04 -55.56% | 0.23 475.00% | 0.35 50.23% | 0.39 12.31% | 0.55 41.24% | N/A | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.13 43.40% | 0.04 -19.20% | 0.08 -20.64% | 0.09 15.43% | 0.15 16.27% |
| Revenue Q2Q % growth | 171.64M 12.16% | 150.83M 12.50% | 166.95M 11.89% | 169.53M 9.83% | 192.7M 12.27% |
| EBITDA Q2Q % growth | 66.307M -29.56% | 47.159M 81.97% | 57.284M 17.21% | 60.051M 0.34% | 75.108M 13.27% |
| EBIT Q2Q % growth | 28.82M -4.45% | 14.494M 53.33% | 20.835M 37.34% | 23.53M 185.52% | 37.546M 30.28% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
33.57%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
12.73%
Revenue Next 5 Year
12.02%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
65.94%
EBIT Next 5 Year
41.75%
INTEGRAL AD SCIENCE HOLDING / IAS Forecast FAQ
What do analysts expect the price target to be for INTEGRAL AD SCIENCE HOLDING (IAS)?
20 analysts have analysed IAS and the average price target is 11.71 USD. This implies a price increase of 13.26% is expected in the next year compared to the current price of 10.34.
What is the next earnings date for IAS stock?
INTEGRAL AD SCIENCE HOLDING (IAS) will report earnings on 2026-02-26, after the market close.
Can you provide the consensus estimates for INTEGRAL AD SCIENCE HOLDING next earnings?
The consensus EPS estimate for the next earnings of INTEGRAL AD SCIENCE HOLDING (IAS) is 0.13 USD and the consensus revenue estimate is 171.64M USD.
What is the expected long term growth rate for IAS stock?
The expected long term growth rate for INTEGRAL AD SCIENCE HOLDING (IAS) is 12.73%.